NCT01501565View on ClinicalTrials.gov

Analgesic Efficacy of Ultrasound-guided Transverse-abdominal Plain Blockade in Urological Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

141

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions
Postoperative Pain
Interventions
PROCEDURE

Postoperative transverse abdominal plain (TAP) blockade

Bupivacaine 0.25%. Maximum 150 mg. A maximum of 75 mg bupivacaine is administered in each side (posterior and subcostal TAP) in a single puncture.

Trial Locations (1)

08025

Fundació Puigvert, Barcelona

All Listed Sponsors
lead

Fundacio Puigvert

OTHER

NCT01501565 - Analgesic Efficacy of Ultrasound-guided Transverse-abdominal Plain Blockade in Urological Surgery | Biotech Hunter | Biotech Hunter